The members listed below represent scientists and physicians across the Vanderbilt community who are leaders in areas relevant to the mission of the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4).
Director
-
Eric P. Skaar, Ph.D., M.P.H.
Director, Institute for Infection, Immunology and Inflammation (VI4)
Executive Positions
-
-
James E. Cassat, M.D., Ph.D.
Associate Director, (VI4)Institute for Infection, Immunology and Inflammation -
Ivelin Georgiev, Ph.D.
Director - Vanderbilt Program in Computational Microbiology and Immunology -
Maria Hadjifrangiskou, Ph.D.
Associate Director, Vanderbilt Institute for Infection, Immunology and Inflammation -
Mary Philip, M.D., Ph.D.
Associate Director, (VI4) Institute for Infection, Immunology and Inflammation -
The Strategic Planning Committee
-
-
-
-
-
-
-
-
Simon A. Mallal, M.B.B.S., F.R.A.C.P., F.R.C.P.A.
Director, Vanderbilt Center for Translational and Clinical Immunology -
-
External Advisory Board
-
William Goldman, Ph.D.
ProfessorUniversity of North Carolina at Chapel Hill -
Lora Hooper, Ph.D.
ProfessorDepartment of Immunology at the University of Texas Southwestern Medical Center -
Scott Hultgren, Ph.D.
Professor of Molecular MicrobiologyDirector of the Center for Women’s Infectious Disease Research at Washington University in St. Louis -
Susan Kaech, Ph.D.
Professor, Salk InstituteDirector of the NOMIS Center for Immunobiology and Microbial Pathogenesis -
Richard Locksley, M.D.
Professor of MedicineDirector of the Sandler Asthma Basic Research (SABRE) Center at the University of California, San Francisco
Staff
-
Megan Schladt, M.S.
Sr Program ManagerVanderbilt Institute for Infection, Immunology & Inflammation (VI4) -
Jamie Block
Program ManagerVanderbilt Institute for Infection, Immunology & Inflammation (VI4) -
Fredrick Haywood
Social Media and Communications Project ManagerPathology, Microbiology and Immunology, Molecular Pathogenesis